
The OJC Episode 7: ASCO Special Episode Part 2
Welcome to Episode 6 of the second series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson for the first ASCO 2024 Special.
Welcome to Episode 6 of the second series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson for the first ASCO 2024 Special.
Welcome to Episode 6 of the second series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson for the first ASCO 2024 Special.
The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy obecabtagene autoleucel (obe-cel) achieved durable remissions…
For patients with locally advanced oesophageal adenocarcinoma that can be treated with surgery, chemotherapy treatment…
Trastuzumab deruxtecan delays cancer growth for people with hormone receptor-positive (HR+), human epidermal growth factor…
New research reinforces telehealth delivery of palliative care as an effective alternative to in-person visits…
A CAR T-cell therapy approved for patients with large B cell lymphoma has produced positive…
Results from a new study demonstrate that consolidation therapy – or treatment given for a…
Osimertinib improves progression-free survival in patients with unresectable stage III EGFR-mutated NSCLC that has been…
Neoadjuvant immunotherapy given for stage III melanoma, followed by adjuvant therapy only if there is…